{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:27:44Z","timestamp":1793284064896,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-04914-y","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T02:20:40Z","timestamp":1743733240000},"page":"4783-4795","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predicting clinically significant prostate cancer in PI-RADS 3 lesions using MRI-based radiomics: a literature review of methodological variations and performance"],"prefix":"10.1007","volume":"50","author":[{"given":"Alejandro","family":"Serrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Louviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmol","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savas","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. C.","family":"Balaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheeraj R.","family":"Gopireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazim Z.","family":"Gumus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"1","key":"4914_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022\/01\/13. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4914_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ucl.2017.07.008","volume":"44","author":"S Damodaran","year":"2017","unstructured":"Damodaran S, Kyriakopoulos CE, Jarrard DF. Newly Diagnosed Metastatic Prostate Cancer: Has the Paradigm Changed? Urol Clin North Am. 2017\/11\/07. 2017;44(4):611\u201321.","journal-title":"Urol Clin North Am"},{"key":"4914_CR3","doi-asserted-by":"publisher","unstructured":"Yao S, Jiang H, Song B. Radiomics in prostate cancer: basic concepts and current state-of-the-art. Chin J Acad Radiol [Internet]. 2020;2(3):47\u201355. Available from: https:\/\/doi.org\/10.1007\/s42058-019-00020-3","DOI":"10.1007\/s42058-019-00020-3"},{"key":"4914_CR4","doi-asserted-by":"crossref","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019\/03\/23. 2019;76(3):340\u201351.","DOI":"10.1016\/j.eururo.2019.02.033"},{"key":"4914_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40644-016-0068-2","volume":"16","author":"P Steiger","year":"2016","unstructured":"Steiger P, Thoeny HC. Prostate MRI based on PI-RADS version 2: how we review and report. Cancer Imaging. 2016\/04\/14. 2016;16:9.","journal-title":"Cancer Imaging"},{"key":"4914_CR6","doi-asserted-by":"crossref","unstructured":"Schoots IG. MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? Transl Androl Urol [Internet]. 2018 Feb 1 [cited 2024 Nov 21];7(1):70\u201382. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29594022\/","DOI":"10.21037\/tau.2017.12.31"},{"key":"4914_CR7","unstructured":"Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, et al. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology [Internet]. 2020 Jul 1 [cited 2024 Nov 21];296(1):76\u201384. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32315265\/"},{"key":"4914_CR8","unstructured":"Grozescu T, Popa F. Prostate cancer between prognosis and adequate\/proper therapy. J Med Life. 2017\/03\/04. 2017;10(1):5\u201312."},{"key":"4914_CR9","doi-asserted-by":"crossref","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, De Jong EEC, Van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol [Internet]. 2017 Dec 1 [cited 2024 Nov 21];14(12):749\u201362. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28975929\/","DOI":"10.1038\/nrclinonc.2017.141"},{"key":"4914_CR10","doi-asserted-by":"publisher","unstructured":"Jing G, Xing P, Li Z, Ma X, Lu H, Shao C, et al. Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram. Front Oncol [Internet]. 2022\/08\/02. 2022;12:918830. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fonc.2022.918830\/full","DOI":"10.3389\/fonc.2022.918830\/full"},{"key":"4914_CR11","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Antes G, Atkins D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med [Internet]. 2009 Jul 1 [cited 2024 Nov 21];6(7). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19621072\/","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"9","key":"4914_CR12","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar JN. Receiver Operating Characteristic Curve in Diagnostic Test Assessment. Journal of Thoracic Oncology. 2010;5(9):1315\u20136.","journal-title":"Journal of Thoracic Oncology"},{"key":"4914_CR13","doi-asserted-by":"crossref","unstructured":"Corsi A, De Bernardi E, Bonaffini PA, Franco PN, Nicoletta D, Simonini R, et al. Radiomics in PI-RADS 3 Multiparametric MRI for Prostate Cancer Identification: Literature Models Re-Implementation and Proposal of a Clinical-Radiological Model. J Clin Med. 2022\/11\/12. 2022;11(21).","DOI":"10.3390\/jcm11216304"},{"key":"4914_CR14","doi-asserted-by":"publisher","first-page":"840786","DOI":"10.3389\/fonc.2022.840786","volume":"12","author":"P Jin","year":"2022","unstructured":"Jin P, Yang L, Qiao X, Hu C, Hu C, Wang X, et al. Utility of Clinical-Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions. Front Oncol. 2022\/03\/15. 2022;12:840786.","journal-title":"Front Oncol"},{"key":"4914_CR15","doi-asserted-by":"crossref","unstructured":"Brancato V, Aiello M, Basso L, Monti S, Palumbo L, Di Costanzo G, et al. Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions. Sci Rep [Internet]. 2021\/01\/14. 2021;11(1):643. Available from: https:\/\/www.nature.com\/articles\/s41598-020-80749-5.pdf","DOI":"10.1038\/s41598-020-80749-5"},{"key":"4914_CR16","first-page":"e782","volume":"08","author":"MD Rappaport","year":"2021","unstructured":"Rappaport MD Fan RE Rusu M Sonn GA BI. MP43-03 Machine learning improves detection of clinically significant prostate cancer in equivocal lesions on mpmri. Journal of Urology. 08\/04\/2021. 2021;206:e782\u2013e782.","journal-title":"Journal of Urology"},{"issue":"2","key":"4914_CR17","first-page":"170","volume":"46","author":"Yang Jing Chen Junfan Luo Yindeng Liu Yuexi","year":"2024","unstructured":"Yang Jing Chen Junfan Luo Yindeng Liu Yuexi. HD. Evaluation of aggressiveness of prostate cancer based on multiparametric MRI radiomics. Journal of Army Medical University. 2024;46(2):170\u201380.","journal-title":"Journal of Army Medical University"},{"key":"4914_CR18","doi-asserted-by":"crossref","unstructured":"Van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res [Internet]. 2017 Nov 1 [cited 2024 Nov 21];77(21):e104. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5672828\/","DOI":"10.1158\/0008-5472.CAN-17-0339"},{"issue":"1","key":"4914_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12880-023-01002-9","volume":"23","author":"P Jin","year":"2023","unstructured":"Jin P, Shen J, Yang L, Zhang J, Shen A, Bao J, et al. Machine learning-based radiomics model to predict benign and malignant PI-RADS v2.1 category 3 lesions: a retrospective multi-center study. BMC Med Imaging. 2023\/03\/30. 2023;23(1):47.","journal-title":"BMC Med Imaging"},{"key":"4914_CR20","doi-asserted-by":"crossref","unstructured":"Song Y, Zhang J, Zhang YD, Hou Y, Yan X, Wang Y, et al. FeAture Explorer (FAE): A tool for developing and comparing radiomics models. PLoS One [Internet]. 2020 Aug 1 [cited 2024 Nov 21];15(8):e0237587. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0237587","DOI":"10.1371\/journal.pone.0237587"},{"key":"4914_CR21","doi-asserted-by":"crossref","unstructured":"Hectors SJ, Chen C, Chen J, Wang J, Gordon S, Yu M, et al. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions. J Magn Reson Imaging. 2021\/05\/11. 2021;54(5):1466\u201373.","DOI":"10.1002\/jmri.27692"},{"key":"4914_CR22","doi-asserted-by":"crossref","unstructured":"Hou Y, Bao ML, Wu CJ, Zhang J, Zhang YD, Shi HB. A radiomics machine learning-based redefining score robustly identifies clinically significant prostate cancer in equivocal PI-RADS score 3 lesions. Abdom Radiol (NY). 2020\/08\/03. 2020;45(12):4223\u201334.","DOI":"10.1007\/s00261-020-02678-1"},{"key":"4914_CR23","doi-asserted-by":"crossref","unstructured":"Zheng H, Miao Q, Liu Y, Raman SS, Scalzo F, Sung K. Integrative Machine Learning Prediction of Prostate Biopsy Results From Negative Multiparametric MRI. J Magn Reson Imaging. 2021\/06\/24. 2022;55(1):100\u201310.","DOI":"10.1002\/jmri.27793"},{"key":"4914_CR24","doi-asserted-by":"publisher","first-page":"825429","DOI":"10.3389\/fonc.2021.825429","volume":"11","author":"T Li","year":"2021","unstructured":"Li T, Sun L, Li Q, Luo X, Luo M, Xie H, et al. Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions. Front Oncol. 2022\/02\/15. 2021;11:825429.","journal-title":"Front Oncol"},{"issue":"12","key":"4914_CR25","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1007\/s00261-021-03235-0","volume":"46","author":"CS Lim","year":"2021","unstructured":"Lim CS, Abreu-Gomez J, Thornhill R, James N, Al Kindi A, Lim AS, et al. Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis. Abdom Radiol (NY). 2021\/09\/02. 2021;46(12):5647\u201358.","journal-title":"Abdom Radiol (NY)"},{"key":"4914_CR26","doi-asserted-by":"publisher","first-page":"1020317","DOI":"10.3389\/fonc.2022.1020317","volume":"12","author":"Y Lu","year":"2022","unstructured":"Lu Y, Li B, Huang H, Leng Q, Wang Q, Zhong R, et al. Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4\u223c10 ng\/mL. Front Oncol. 2022\/12\/31. 2022;12:1020317.","journal-title":"Front Oncol"},{"key":"4914_CR27","doi-asserted-by":"publisher","unstructured":"Zhao YY, Xiong ML, Liu YF, Duan LJ, Chen JL, Xing Z, Lin YS, Chen TH. Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone. Front Oncol. 2023 Nov 23;13:1247682. PMID: 38074651; PMCID: PMC10701731. https:\/\/doi.org\/10.3389\/fonc.2023.1247682","DOI":"10.3389\/fonc.2023.1247682"},{"key":"4914_CR28","doi-asserted-by":"crossref","unstructured":"Shur JD, Doran SJ, Kumar S, Ap Dafydd D, Downey K, O\u2019connor JPB, et al. Radiomics in Oncology: A Practical Guide. Radiographics [Internet]. 2021 Oct 1 [cited 2024 Nov 25];41(6):1717\u201332. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34597235\/","DOI":"10.1148\/rg.2021210037"},{"key":"4914_CR29","doi-asserted-by":"crossref","unstructured":"Zhang YP, Zhang XY, Cheng YT, Li B, Teng XZ, Zhang J, et al. Artificial intelligence-driven radiomics study in cancer: the role of feature engineering and modeling. Mil Med Res [Internet]. 2023 Dec 1 [cited 2024 Nov 25];10(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37189155\/","DOI":"10.1186\/s40779-023-00458-8"},{"key":"4914_CR30","doi-asserted-by":"crossref","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA, Aerts H, Andrearczyk V, Apte A, et al. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology. 2020\/03\/11. 2020;295(2):328\u201338.","DOI":"10.1148\/radiol.2020191145"},{"key":"4914_CR31","doi-asserted-by":"publisher","unstructured":"Girometti R, Giannarini G, Panebianco V, Maresca S, Cereser L, De Martino M, et al. Comparison of different thresholds of PSA density for risk stratification of PI-RADSv2.1 categories on prostate MRI. British Journal of Radiology [Internet]. 2022 Mar 1 [cited 2024 Nov 22];95(1131). Available from: https:\/\/doi.org\/10.1259\/bjr.20210886","DOI":"10.1259\/bjr.20210886"},{"key":"4914_CR32","doi-asserted-by":"crossref","unstructured":"Roscigno M, Stabile A, Lughezzani G, Pepe P, Galosi AB, Naselli A, et al. The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification? Clin Genitourin Cancer [Internet]. 2020 Dec 1 [cited 2024 Nov 22];18(6):e698\u2013704. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32493676\/","DOI":"10.1016\/j.clgc.2020.04.006"},{"key":"4914_CR33","doi-asserted-by":"crossref","unstructured":"Scalco E, Belfatto A, Mastropietro A, Rancati T, Avuzzi B, Messina A, et al. T2w-MRI signal normalization affects radiomics features reproducibility. Med Phys [Internet]. 2020 Apr 1 [cited 2024 Nov 22];47(4):1680\u201391. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31971614\/","DOI":"10.1002\/mp.14038"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-04914-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-04914-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-04914-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:08:19Z","timestamp":1758719299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-04914-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4914"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-04914-y","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}